ArticleOpen forum infectious diseases2024

Implementation of Injectable Cabotegravir/Rilpivirine for Treatment of Human Immunodeficiency Virus in Patients With Substance Use Disorders at a Syringe Exchange Clinic.

Amanda Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.